H.R. 1613 - Drug Pri
H.R. 1613 - Drug Price Transparency in Medicaid Act Washington, DC, March 17, 2023 (GLOBE NEWSWIRE) -- On Friday, United States Representatives Buddy Carter (R-GA), Vicente Gonzalez D-TX), Elise Stefanik (R-NY), Deborah Ross (D-NC), Rick Allen...
CMS Takes Action to
CMS Takes Action to Address Pharmacy DIR Clawbacks That Harm Specialty Patients and Pharmacies
07 janv. 2022 13h50 HE | National Association of Specialty Pharmacy (NASP)
Washington, DC, Jan. 07, 2022 (GLOBE NEWSWIRE) -- On Thursday, the Centers for Medicare and Medicaid Services released a proposed rule that would require Part D plans to apply all price concessions...